Effects of Exercise Training on Myocardial Energy Metabolism and Ventricular Function Assessed by Quantitative Phosphorus-31 Magnetic Resonance Spectroscopy and Magnetic Resonance Imaging in Dilated Cardiomyopathy

Journal of the American College of Cardiology

Volumn 51, Issue 19, 2008, Pages 1883-1891

  Beer, Meinrad ^a   Wagner, Doris ^b   Myers, Jonathan ^c   Sandstede, Jörn ^a   Köstler, Herbert ^a   Hahn, Dietbert ^a   Neubauer, Stefan ^d   Dubach, Paul ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE PHOSPHATE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AEROBIC EXERCISE; AEROBIC METABOLISM; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE METABOLISM; HEART RIGHT VENTRICLE FUNCTION; HEART VOLUME; HIGH ENERGY PHOSPHATE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN CONSUMPTION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS;

CARDIOMYOPATHY, DILATED; ENERGY METABOLISM; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MYOCARDIUM; PHOSPHORUS ISOTOPES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 42949089409     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.09.075     Document Type: Article

References (43)

1. Ingwall J.S., Kramer M.F., Fifer M.A., et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 313 (1985) 1050-1054
2. Ingwall J.S., Atkinson D.E., Clarke K., and Fetters J.K. Energetic correlates of cardiac failure: changes in the creatine kinase system in the failing myocardium. Eur Heart J 11 Suppl B (1990) 108-115
3. Pohost G.M., Meduri A., Razmi R.M., Rathi V.K., and Doyle M. Cardiac MR spectroscopy in the new millennium. Rays 26 (2001) 93-107
4. Bottomley P.A. MR spectroscopy of the human heart: the status and the challenges. Radiology 191 (1994) 593-612
5. Beer M., Seyfarth T., Sandstede J., et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 40 (2002) 1267-1274
6. Neubauer S., Krahe T., Schindler R., et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86 (1992) 1810-1818
7. Neubauer S., Horn M., Cramer M., et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96 (1997) 2190-2196
8. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
9. Pfeffer M.A., Braunwald E., Moye L.A., et al., The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 327 (1992) 669-677
10. CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90 (1994) 1765-1773
11. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334 (1996) 1349-1355
12. Feldman A.M., and Bristow M.R. The beta-adrenergic pathway in the failing human heart: implications for inotropic therapy. Cardiology 77 Suppl 1 (1990) 1-32
13. Packer M., Carver J.R., Rodeheffer R.J., et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325 (1991) 1468-1475
14. Piepoli M.F., Flather M., and Coats A.J. Overview of studies of exercise training in chronic heart failure: the need for a prospective randomized multicentre European trial. Eur Heart J 19 (1998) 830-841
15. Coats A.J., Adamopoulos S., Radaelli A., et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 85 (1992) 2119-2131
16. Myers J., Wagner D., Schertler T., et al. Effects of exercise training on left ventricular volumes and function in patients with nonischemic cardiomyopathy: application of magnetic resonance myocardial tagging. Am Heart J 144 (2002) 719-725
17. Hambrecht R., Gielen S., Linke A., et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomized trial. JAMA 283 (2000) 3095-3101
18. Piepoli M.F., Davos C., Francis D.P., and Coats A.J. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 328 (2004) 189
19. Smart N., and Marwick T.H. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med 116 (2004) 693-706
20. Belardinelli R., Georgiou D., Cianci G., and Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 99 (1999) 1173-1182
21. Ukkonen H., Beanlands R.S., Burwash I.G., et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation 107 (2003) 28-31
22. Stolen K.Q., Kemppainen J., Ukkonen H., et al. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency in patients with dilated cardiomyopathy. J Am Coll Cardiol 41 (2003) 460-467
23. Boesch C., Myers J., Habersaat A., Ilarraza H., Kottman W., and Dubach P. Maintenance of exercise capacity and physical activity patterns 2 years after cardiac rehabilitation. J Cardiopulm Rehabil 25 (2005) 14-21 quiz 22-3
24. Sandstede J., Lipke C., Beer M., et al. Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol 10 (2000) 438-442
25. Meininger M., Landschutz W., Beer M., et al. Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy. Magn Reson Med 41 (1999) 657-663
26. Vanhamme L., van den Boogaart A., and Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129 (1997) 35-43
27. Bengel F.M., Permanetter B., Ungerer M., Nekolla S., and Schwaiger M. Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate-comparison between the normal and failing human heart. Eur J Nucl Med 27 (2000) 319-326
28. McKelvie R.S., Teo K.K., Roberts R., et al. Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT). Am Heart J 144 (2002) 23-30
29. Laughlin M.H., and McAllister R.M. Exercise training-induced coronary vascular adaptation. J Appl Physiol 73 (1992) 2209-2225
30. Giannuzzi P., Temporelli P.L., Corra U., and Tavazzi L. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial. Circulation 108 (2003) 554-559
31. Ilarraza H., Myers J., Kottman W., Rickli H., and Dubach P. An evaluation of training responses using self-regulation in a residential rehabilitation program. J Cardiopulm Rehabil 24 (2004) 27-33
32. Webb-Peploe K.M., Chua T.P., Harrington D., Henein M.Y., Gibson D.G., and Coats A.J. Different response of patients with idiopathic and ischaemic dilated cardiomyopathy to exercise training. Int J Cardiol 74 (2000) 215-224
33. Belardinelli R., Georgiou D., Ginzton L., Cianci G., and Purcaro A. Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy. Circulation 97 (1998) 553-561
34. Packer M., Lee W.H., Medina N., and Yushak M. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure. J Am Coll Cardiol 6 (1985) 635-645
35. Di Salvo T.G., Mathier M., Semigran M.J., and Dec G.W. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 25 (1995) 1143-1153
36. Sanbe A., Tanonaka K., Hanaoka Y., Katoh T., and Takeo S. Regional energy metabolism of failing hearts following myocardial infarction. J Mol Cell Cardiol 25 (1993) 995-1013
37. Okada M., Mitsunami K., Inubushi T., and Kinoshita M. Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS. Magn Reson Med 39 (1998) 772-782
38. Schneider-Gold C., Beer M., Kostler H., et al. Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. Muscle Nerve 30 (2004) 636-644
39. Lamb H.J., Beyerbacht H.P., Ouwerkerk R., et al. Metabolic response of normal human myocardium to high-dose atropine-dobutamine stress studied by 31P-MRS. Circulation 96 (1997) 2969-2977
40. Zhang J., Ugurbil K., From A.H., and Bache R.J. Use of magnetic resonance spectroscopy for in vivo evaluation of high-energy phosphate metabolism in normal and abnormal myocardium. J Cardiovasc Magn Reson 2 (2000) 23-32
41. McCrohon J.A., Moon J.C., Prasad S.K., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 (2003) 54-59
42. Grothues F., Moon J.C., Bellenger N.G., Smith G.S., Klein H.U., and Pennell D.J. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 147 (2004) 218-223
43. Weiss R.G., Gerstenblith G., and Bottomley P.A. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A 102 (2005) 808-813